Publications by authors named "Anna Polikarpova"

Claim this Profile
E
Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications.
Tatiana Egorova, Anna Starikova, Anna Polikarpova

Pharmaceutics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VBIT-4 Rescues Mitochondrial Dysfunction and Reduces Skeletal Muscle Degeneration in a Severe Model of Duchenne Muscular Dystrophy.
Mikhail V Dubinin, Anastasia E Stepanova, Irina B Mikheeva, Anastasia D Igoshkina, Ekaterina N Kraeva, Anna V Polikarpova

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G>A linked to encephalopathy.
Evgenii A Lunev, Natalia V Klementieva, Svetlana G Vassilieva, Egor A Volovikov, David Jappy, Anna V Polikarpova

Gene Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA Interference Effectors Selectively Silence the Pathogenic Variant c.607 G > A .
Natalia V Klementieva, Evgenii A Lunev, Anna A Shmidt, Elizaveta M Loseva, Irina M Savchenko, Anna V Polikarpova

Nucleic Acid Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein.
Tatiana V Egorova, Anna V Polikarpova, Svetlana G Vassilieva, Marina A Dzhenkova, Irina M Savchenko

Mol Ther Methods Clin Dev· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-Frame Deletion of Dystrophin Exons 8-50 Results in DMD Phenotype.
Tatiana V Egorova, Ivan I Galkin, Oleg A Velyaev, Svetlana G Vassilieva, Irina M Savchenko, Anna V Polikarpova

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the for safety studies of RNA therapeutics.
Anna V Polikarpova, Tatiana V Egorova, Evgenii A Lunev, Alexandra A Tsitrina, Svetlana G Vassilieva

Front Genome Ed· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression.
Anna V Starikova, Victoria V Skopenkova, Anna V Polikarpova, Denis A Reshetov, Svetlana G Vassilieva

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin.
Kirill A Danilov, Svetlana G Vassilieva, Anna V Polikarpova, Anna V Starikova, Anna A Shmidt

Exp Cell Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human gene.
Tatiana V Egorova, Evgenia D Zotova, Denis A Reshetov, Anna V Polikarpova, Svetlana G Vassilieva

Dis Model Mech· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progesterone inhibits proliferation and modulates expression of proliferation-Related genes in classical progesterone receptor-negative human BxPC3 pancreatic adenocarcinoma cells.
Alexey I Goncharov, Aitsana A Maslakova, Anna V Polikarpova, Elena A Bulanova, Alexandra A Guseva

J Steroid Biochem Mol Biol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis